A Kent and Medway Cancer Network (KMCN) audit of first-line treatment with cisplatin/pemetrexed (CisPem) in non squamous non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Letsa, I. [1 ]
Mikropoulos, C. [1 ]
Burcombe, R. [1 ]
Visioli, A. [1 ]
Sevitt, T. [1 ]
Cominos, M. [1 ]
Beesley, S. [1 ]
机构：
[1] Maidstone Hlth Author, Kent Oncol Ctr, Maidstone, Kent, England
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
10.1016/S0169-5002(11)70019-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
    Chang, John Wen-Cheng
    Thongprasert, Sumitra
    Wright, Elaine
    Tsang, Kenneth
    Kim, Heung Tae
    Ahn, Myung-Ju
    Kim, Joo-Hang
    Kang, Jin Hyoung
    Kim, Sang-We
    Walzer, Stefan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 13 - 21
  • [32] Pemetrexed for the treatment of non-small cell lung cancer
    Genova, Carlo
    Rijavec, Erika
    Truini, Anna
    Coco, Simona
    Sini, Claudio
    Barletta, Giulia
    Dal Bello, Maria Giovanna
    Alama, Angela
    Savarino, Grazia
    Pronzato, Paolo
    Boccardo, Francesco
    Grossi, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (11) : 1545 - 1558
  • [33] Cost-Effectiveness of Pemetrexed Plus Cisplatin as First-Line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer
    Klein, Robert
    Muehlenbein, Catherine
    Liepa, Astra M.
    Babineaux, Steve
    Wielage, Ron
    Schwartzberg, Lee
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : 1404 - 1414
  • [34] First-line cisplatin plus pemetrexed therapy for selected patients with advanced nonsquamous non-small cell lung cancer.
    Nakashima, Kazuhisa
    Murakami, Haruyasu
    Imai, Hisao
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Endo, Masahiro
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Pemetrexed in the treatment of non-small cell lung cancer
    Shepherd, FA
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 43 - 48
  • [36] Efficacy and tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC)
    Binder, D.
    Hackenthal, M.
    Graseck, L.
    Schweisfurth, H.
    Schaeper, C.
    Kruell, M.
    Temmesfeld-Wollbrueck, B.
    Suttorp, N.
    Beinert, T.
    Hellriegel, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
    Andric, Z. G.
    Galffy, G.
    Cobo Dols, M.
    Szima, B.
    Stojanovic, G.
    Petrovic, M. D.
    Felip Font, E.
    Vicente Baz, D.
    Ponce Aix, S.
    Juan-Vidal, O.
    Tehenes, S.
    Szalai, Z.
    Losonczy, G.
    Calles Blanco, A.
    Bernabe, R.
    Duecker, K.
    Zhou, D.
    Schroeder, A.
    Guezel, G.
    Ciardiello, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S753 - S754
  • [38] Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the US
    Kumar, Gayathri
    Woods, Beth
    Hess, Lisa M.
    Treat, Joseph
    Boye, Mark E.
    Bryden, Peter
    Winfree, Katherine B.
    LUNG CANCER, 2015, 89 (03) : 294 - 300
  • [39] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    ONKOLOGIE, 2003, 26 : 26 - 32
  • [40] EFFECTIVENESS OF FIRST-LINE PEMETREXED PLUS PLATINUM FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Brandao, M. D. R. A.
    Luis, M. S.
    Amaral, N. C.
    Cassiano Neves, M.
    Camacho, C.
    Rodrigues, A. C.
    Pousa, I.
    Oliveira, J.
    Azevedo, I.
    ANNALS OF ONCOLOGY, 2015, 26
12345